Corpus Intelligence IC Memo — TENNOVA HEALTHCARE CLARKSVILLE 2026-04-26 06:41 UTC
IC Memo — TENNOVA HEALTHCARE CLARKSVILLE
Investment Committee Memorandum | TN | 238 beds | Grade C | EBITDA uplift $15.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TENNOVA HEALTHCARE CLARKSVILLE

CCN 440035 | MONTGOMERY, TN | 238 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TENNOVA HEALTHCARE CLARKSVILLE is a 238-bed suburban community hospital in MONTGOMERY, TN with $203.6M in net patient revenue and a 7.4% operating margin. The hospital serves a payer mix of 27.5% Medicare, 4.3% Medicaid, and 68.2% commercial.

Thesis: Platform Growth. Our ML models identify $15.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.4% to 14.8% (+736bps).

Net Revenue HCRIS$203.6M
Current EBITDA COMPUTED$15.1M
Operating Margin COMPUTED7.4%
Occupancy HCRIS51.3%
Revenue / Bed COMPUTED$855K
Net-to-Gross HCRIS12.9%
Distress Probability ML46.9%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
27
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 7.4% places it above the state median. Among 27 size-comparable peers (119-476 beds), the median margin is 1.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (119-476), prioritizing same-state peers. 27 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TENNOVA HEALTHCARE CLARKSVILLE (Target)TN238$203.6M7.4%
MEMORIAL HEALTH CARE SYSTEM INTN431$583.9M-9.0%
SAINT THOMAS RUTHERFORD HOSPITTN354$447.4M1.3%
PARKRIDGE MEDICAL CENTERTN396$433.4M30.1%
REGIONAL ONE HEALTHTN291$407.9M-50.0%
PARKWEST MEDICAL CENTERTN361$396.4M-5.5%
COOKEVILLE REGIONAL MEDICAL CETN212$372.5M2.1%
SKYLINE MEDICAL CENTERTN350$360.4M15.1%
FORT SANDERS REGIONAL MEDICAL TN304$346.2M-9.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.3M+210bp18mo
Cost to Collect4.5%2.5%$4.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.5M+122bp9mo
Clean Claim Rate88.0%96.0%$130K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.3M
Cost to Collect
$4.1M
Denial Rate Reduction
$4.0M
A/R Days Reduction
$2.5M
Clean Claim Rate
$130K
Total EBITDA Uplift$15.0M
Current EBITDA$15.1M
+ RCM Uplift+$15.0M
Pro Forma EBITDA$30.0M
Current Margin7.4%
Pro Forma Margin14.8%
WC Released (1x)$7.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$23.2M$249.1M10.76x60.8%
Base (11x exit)10.0x11.0x$23.2M$281.6M12.16x64.8%
Bull Case9.0x11.0x$20.8M$338.6M16.25x74.6%
Bull (12x exit)9.0x12.0x$20.8M$375.5M18.02x78.3%
Bear Case11.0x10.0x$25.5M$166.7M6.54x45.6%
Bear (11x exit)11.0x11.0x$25.5M$191.6M7.52x49.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 27 hospitals with 119-476 beds
  • Same-state prioritization (n=28)
  • Comp margins: P25=-8.5% / P50=1.5% / P75=11.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.